(Q28279362)
Statements
Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study (English)
0 references
Ranibizumab for Macular Edema following Central Retinal Vein Occlusion (English)
1 reference
Zhengrong Li
1 reference
Sarah Gray
1 reference
Namrata Saroj
1 reference
Amy Chen Rundle
1 reference
Wendy Yee Murahashi
1 reference
David M. Brown
1 reference
Peter A. Campochiaro
1 reference
Rishi P. Singh
1 reference
Roman G. Rubio
1 reference
June 2010
1 reference
1 reference
117
1 reference
6
1 reference
1124-1133.e1
1 reference